Bayer unveils medical breakthroughs

Bayer unveils medical breakthroughs

Bayer is set to embark on its next phase of growth with a new wave of medical breakthroughs.
Global pharma expects bumper year

Global pharma expects bumper year

Increasing footprints in Vietnam in 2023, multinational corporations continue to eye stronger local partnerships to bring more new innovative medicines and vaccines to the local market in 2024 and beyond.
Legal landscape adjusted for global pharma groups

Legal landscape adjusted for global pharma groups

Multinational corporations operating in Vietnam are expected to benefit from new legal changes in the months to come, after years of delay.
Local pharma giants reaping rewards with new strategies

Local pharma giants reaping rewards with new strategies

While the shift to the hospital channel brought fruitful results for major pharma players in Vietnam in 2023, competition is forecast to heat up in the future.
Vietnam's pharmaceutical market: burgeoning $7 billion industry

Vietnam's pharmaceutical market: burgeoning $7 billion industry

Vietnam's pharmaceutical industry was valued at up to $7 billion in 2022.
Fluctuations felt in pharma retail sphere

Fluctuations felt in pharma retail sphere

The race in Vietnam’s pharmaceutical retail industry is becoming a tough arena for major players.
The way out for pharma distribution

The way out for pharma distribution

Vietnam needs to open up its pharmaceutical distribution and logistics activities, but such changes will take time.
Opening the domestic arena to pharma distribution

Opening the domestic arena to pharma distribution

Vietnam’s pharmaceutical market is one of the fastest growing markets in the world. However, although the market is growing rapidly, production capacity can only meet about half of domestic demand.
ASKA Pharmaceutical to secure 33 per cent stake in Hataphar

ASKA Pharmaceutical to secure 33 per cent stake in Hataphar

Japanese Firm ASKA Pharmaceutical is set to acquire nearly 33 per cent equity in Vietnam's Ha Tay Pharmaceuticals (Hataphar).
South Korean Dongwha Pharm buys majority stake in Vietnam's Trung Son Pharma

South Korean Dongwha Pharm buys majority stake in Vietnam's Trung Son Pharma

The retail pharmaceutical landscape in Vietnam is poised for further heating up as Dongwha Pharm, a South Korean conglomerate, joins the fray.
Legal tweaks could unlock potential

Legal tweaks could unlock potential

Market players are expecting legal improvements in the pharma and healthcare market. Bui Thi Viet Lam, Vietnam country representative of the US-ASEAN Business Council, discussed how important regulatory changes are to its member companies’ strategies here, with VIR’s Bich Thuy.
Pharma innovation can come from global experience

Pharma innovation can come from global experience

Innovation has become an inevitable trend in the pharma-healthcare sector, which requires new approaches to tap into its potential and encourage stakeholders to join in.
Investment required for strong healthcare

Investment required for strong healthcare

Vietnam has overcome many hardships and taken enormous strides forward in improving health and quality of life. There has been significant progress towards ending ongoing epidemics of infectious diseases.
More effort needed to increase pharma readiness

More effort needed to increase pharma readiness

Amid existing challenges and new investment approaches towards innovation and science and technology, the pharma-healthcare sector is working to tap into these trends, while developing and enhancing regulations.
Opportunities abound for innovative pharma industry

Opportunities abound for innovative pharma industry

Countries around the world are hoping to entice investment for their innovative pharmaceutical industries in order to bring socioeconomic benefits towards sustainable development strategies.
|< < 1 2 3 4 > >|